Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 8, 2009 - Issue 1
Submit an article Journal homepage
116
Views
9
CrossRef citations to date
0
Altmetric
Review

Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safety

Jean-Luc Pasquié INSERM U637, Université Montpellier1 and 2, CHU Montpellier, Département de Cardiologie, F34295 Montpellier, France
, MD PhD &
Sylvain Richard INSERM U637, Université Montpellier1 and 2, CHU Montpellier, Department of Cardiovascular Physiopathology, 371 avenue du Doyen Gaston Giraud, F34295 Montpellier Cedex 5, France +33 4 67 41 52 41; +33 4 67 41 52 42; [email protected]
, PhD
Pages 57-72 | Published online: 17 Jan 2009

Bibliography

  • Carpentier D, Zuckler EJ, Avorn J. Drug-review and safety problems. N Engl J Med 2008;358:1354-61
  • Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007;7:9
  • Antzelevitch C. Ionic, molecular and cellular bases of QT-interval prolongation and torsade de pointes. Europace 2007;9:IV5-15
  • Liu Ruan, Priori. Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 2008;51(1):23-30
  • Available from: http://www.fsm.it/cardmoc
  • Jiang D, Xiao B, Zhang L, Chen SR. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 2002;91:218-25
  • Terentyev D, Nori A, Santoro M, et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006;98(9):1151-8
  • George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003;93:531-40
  • Priori SG, Napolitano C. Intracellular calcium handling dysfunction and arrhythmogenesis: a new challenge for the electrophysiologist. Circ Res 2005;97(11):1077-9
  • George CH, Jundi H, Thomas NL, et al. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies. J Mol Cell Cardiol 2007;42:34-50
  • Györke S, Carnes C. Dysregulated sarcoplasmic reticulum calcium release: Potential pharmacological target in cardiac disease. Pharmacol Ther 2008;119(3):340-54
  • Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 2001;33(4):615-24
  • Wehrens XH, Lehnart SE, Reiken SR, et al. Protection from cardiac arrhythmia through ryanodine receptor stabilizing protein calstabin2. Science 2004;304:292-6
  • Yano M, Okuda S, Oda T, et al. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. Circulation 2005;112(23):3633-43
  • Pott C, Goldhaber JI. Is the ryanodine receptor a target for antiarrhythmic therapy? Circ Res 2006;98:1232-3
  • Yamamoto T, Yano M, Xu X, et al. Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 2008;117(6):762-72
  • Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22
  • Shah RR. Drugs, QTc interval prolongation and final ICH E14 guideline: an important milestone with challenges ahead. Drug Saf 2005;28:1009-28
  • Hondeghem LM. QT prolongation is an unreliable predictor of ventricular arrhythmias. Heart Rhythm 2005;5:1210-12
  • Roden DM. Long-QT syndrome. N Engl J Med 2008;358:169-76; Roden DM. Drug-induced prolongation of the QT interval. N Eng J Med 2004;350:1013-22
  • Available from: http://www.torsades.org
  • Available from: http://www.Long-QT-Syndrome.com
  • De Bruin ML, Langendijk PN, Koopmans RP, et al. In-hospital cardiac arrest is associated with the use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007;63:216-23
  • Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47(2):362-7
  • Antzelevitch C. Heterogeneity and cardiac arrhythmias. Heart Rhythm 2007;4: 964-72
  • Roden DM. Long-QT syndrome. N Engl J Med 2008;358:169-76
  • Schwarz PJ, Priori SG, Napolitano C. How really rare are the rare diseases? The intringuing case of independent compound mutations in the long QT syndrome. J Cardiovasc Electrophysiol 2003;14:1120-1
  • Yan GX, Lankipalli RS, Burke JF, et al. Ventricular repolarization components on the electrocardiogram. J Am Coll Cardiol 2003;42:401-409
  • Roden DM. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 2006;259:59-69
  • Chevalier P, Bellocq C, Millat G, et al. Torsades de Pointe complicating atrioventricular block: evidence for a genetic predisposition. Heart Rhythm 2007;4:170-174
  • Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-63
  • Sanguinetti MC, Benett PB. Antiarrhythmic drug target choice and screening. Circ Res 2003;96:491-9
  • Mitcheson JS, Chen J, Lin M, et al. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000;97:12329-33
  • Yang P, Kanki H, Drolet B. Allelic variants in long QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002;105:1943-8
  • Viskin S, Rosovski U, Sands AJ, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005;2:569-74
  • Fenichel RR, Malik M, Antzelevitch C. Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol 2004;15:475-95
  • Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84:1136-44
  • Kamran A, Dorian P. Drug-induced QT prolongation and proarrhythmia: an inevitable link? Europace 2007;9(Suppl 4):16-22
  • Malik M, Hnatkova K, Batcharov V. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QT prolongation. PACE 2004;27:791-800
  • Stramba-Badiale M, Priori SG, Napolitano C, et al. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J 2000;1:323-8
  • Gilmour RF, Riccio ML, Locati EH, et al. Time and rate dependent alterations of the QT interval precede the onset of torsades de pointes in patients with acquired QT prolongation. J Am Coll Cardiol 1997;30:209-17
  • Noda T, Shimizu W, Satomi K, et al. Classification and mechanisms of torsades de pointes initiation in patients with congenital long QT syndrome. Eur Heart J 2004;25:2149-54
  • Antzelevitch C. Drug-induced spatial dispersion of repolarization. Cardiol J 2008;15(2):100-21
  • Sahu P, Lim PO, Rana BS, Struthers AD. QT dispersion in medicine: electrophysiological holy grail or fool's gold? QJM 2000;93:425-31
  • Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001;96:517-27
  • Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrohysiological properties in the deep subepicardium of the canine ventricles: the M cells. Circ Res 1991;68:1729-41
  • Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (Ikr and Iks) in canine ventricular epicardial, midmyocardial and endocardial myocytes. Circ Res 1995;76:351-65
  • Zygmunt AC, Goodrow RJ, Antzelevitch C. INa-Ca contributes to electrical heterogeneity within the canine ventricle. Am J Physiol 2000;278:H1671-8
  • Shah RR, Hondeghem LM. Refining detection of drug-induced proarrhythmia: QT intervl and TRIaD. Heart Rhythm 2005;2:758-72
  • Hondeghem LM, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but APD prolongation is antiarrhythmic. Circulation 2001;103:2004-13
  • Hondeghem LM. Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct. Eur J Pharmacol 2008;584(1):1-9
  • Roden DM. Keep the QT interval: it is a reliable predictor of ventricular arrhythmias. Heart Rhythm 2008;5(8):1213-5
  • Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91(5):1512-9
  • Francis J, Sankar V, Nair VK, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2005;2:550-4
  • Mohamed U, Napolitano C, Priori S. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2007;18:791-7
  • Priori SG, Napolitano C, Tiso N, et al. Sorrentino VV, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200
  • Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90
  • Viatchenko-Karpinski S, Terentyev D, Györke I, et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004;94(4):471-7
  • Lehnart SE, Mongillo M, Bellinger A, et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 2008;118(6):2230-45
  • Priori SG, Napolitano C. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J Clin Invest 2005;115:2033-8
  • Fabiato A, Fabiato F. Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 1979;41:473-84
  • Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415(6868):198-205
  • Pogwizd SM, Bers DM. Cellular basis of arrhythmias in heart failure. Trends Cardiovasc Med 2004;14:61-66
  • Bénitah JP, Gómez AM, Fauconnier J, et al. Voltage-gated Ca2+ currents in the human pathophysiologic heart: a review. Basic Res Cardiol 2002;97(Suppl 1):I11-8
  • Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004;61(2):208-17
  • Tomaselli GRD. Conceptual Basis For cardiac Arrhythmology. Molecular and Cellular Basis of cardiac Electrophysiology. In: Saksena SCA, editor, Electrophysiological Disorders of the Heart. Philadelphia: Elsevier; 2005;1035:1-31
  • Richard S, Perrier E, Fauconnier J, et al. ‘Ca(2+)-induced Ca(2+) entry’ or how the L-type Ca(2+) channel remodels its own signalling pathway in cardiac cells. Prog Biophys Mol Biol 2006;90(1-3):118-35
  • Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85(3):1046-55
  • Bers DM, Eisner DA, Valdivia HH. Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ Res 2003;93(6):487-90
  • Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006;3(1):43-52
  • Pogwizd SM, Schlotthauer K, Li L, et al. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88(11):1159-67
  • Fauconnier J, Lacampagne A, Rauzier JM, et al. Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure? Cardiovasc Res 2005;68(2):204-12
  • Fauconnier J, Lacampagne A, Rauzier JM, et al. Frequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells. Am J Physiol Heart Circ Physiol 2005;288(2):H778-86
  • Jiang D, Wang R, Xiao B, et al. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 2005;97(11):1173-81
  • Jiang D, Chen W, Wang R, et al. Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death. Proc Natl Acad Sci USA 2007;104(46):18309-14
  • Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000;101(4):365-76
  • Meissner G. Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 2004;35(6):621-8
  • Wehrens XHT, Lehnart SE, Reiken SR, Marks AR. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 2004;94: 61-70
  • Bers DM. Cardiac ryanodine receptor phosphorylation: target sites and functional consequences. Biochem J 2006;396(Pt 1):e1
  • Benkusky NA, Weber CS, Scherman JA, et al. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ Res 2007;101(8):819-29
  • Xiao B, Zhong G, Obayashi M, et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon Beta-adrenergic stimulation in normal and failing hearts. Biochem J 2006;396:7-16
  • Wang W, Zhu W, Wang S, et al. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ Res 2004;95(8):798-806
  • Curran J, Hinton MJ, Ríos E, et al. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase? Circ Res 2007;100(3):391-8
  • Sipido KR. CaM or cAMP: linking beta-adrenergic stimulation to ‘leaky’ RyRs. Circ Res 2007;100(3):296-8
  • Lam E, Martin MM, Timerman AP, et al. A novel FK-506 binding protein can mediate the immunosuppressive effects of FK-506 and is associated with the cardiac ryanodine receptor. J Biol Chem 1995;270(44):26511-22
  • Xiao RP, Valdivia HH, Bogdanov K, et al. The immunophilin FK-506-binding protein modulates Ca2+ release channel closure in rat heart. J Physiol 1997;500:343-54
  • Gomez AM, Schuster I, Fauconnier J, et al. FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2004;287(5):H1987-93
  • Sood S, Chelu MG, van Oort RJ, et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 2008;5(7):1047-54
  • Wehrens XH, Lehnart SE, Huang F, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003;113(7):829-40
  • Loughrey CM, Seidler T, Miller SL, et al. Over-expression of FK-506-binding protein FKBP12.6 alters excitation-contraction coupling in adult rabbit cardiomyocytes. J Physiol 2004;556:919-34
  • Gellen B, Fernández-Velasco M, Briec F, et al. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 2008;117(14):1778-86
  • Reiken S, Gaburjakova M, Gaburjakova J, et al. beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 2001;104(23):2843-8
  • Doi M, Yano M, Kobayashi S, et al. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. Circulation 2002;105(11):1374-9
  • Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42(11):863-70
  • Yano M, Doi M, Oda T, et al. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation 2004;109(7):911-9
  • Kaneko N. New 1,4-benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res 1994;33:429-38
  • Kohno M, Yano M, Kobayashi S, et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. Am J Physiol 2003;284:H1035-42
  • Hove-Madsen L, Llach A, Bayes-Genís A, et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110(11):1358-63
  • Chen YJ, Chen YC, Wongcharoen W, et al. Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes. Br J Pharmacol 2008;153(5):915-25
  • Wehrens XH, Lehnart SE, Marks AR. Ryanodine receptor-targeted anti-arrhythmic therapy. Ann NY Acad Sci 2005;1047:366-75
  • Yano M, Kobayashi S, Kohno M, et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 2003;107:477-84
  • Priori SG, Mantica M, Schwartz PJ. Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation 1988;78:178-85
  • Ferrier GR, Moe GK. Effect of calcium on acetylstophantidin-induced transient depolarizations in canine Purkinje tissue. Circ Res 1973;33:508-15
  • Rosen MR, Gelband H, Merker C, Hoffman BF. Mechanisms of digitalis toxicity: effects of ouabain on phase 4 of canine Purkinje fiber transmembrane potential. Circulation 1973;47:681-9
  • Lederer WJ, Tsien RW. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibers. J Physiol 1976;263:73-100
  • Levi AJ, Dalton GR, Hancox JC, et al. Role of intracellular sodium overload in the genesis of cardiac arrhythmias. J Cardiovasc Electrophysiol 1997;8(6):700-21
  • Poindexter BJ, Feng W, Dasgupta A, Bick RJ. Oleandrin produces changes in intracellular calcium levels in isolated cardiomyocytes: a real-time fluorescence imaging study comparing adult to neonatal cardiomyocytes. J Toxicol Environ Health A 2007;70:568-74
  • Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J Am Med Assoc 2002;287:1541-7
  • Johnson MC, So S, Marsh JW, Murphy AM. QT prolongation and Torsades de Pointes after administration of FK-506. Transplantation 1992;53(4):929-30
  • Nishimura M, Kim K, Uchiyama A, et al. Tacrolimus-induced life-threatening arrhythmia in a pediatric liver-transplant patient. Intensive Care Med 2002;28(11):1683-4
  • Sawabe T, Mizuno S, Gondo H, et al. Sinus arrest during tacrolimus (FK-506) and digitalis treatment in a bone marrow transplant recipient. Transplantation 1997;64(1):182-3
  • Gerhardt U, Suwelack B, Pawolka A, Hohage H. High QT dispersion in tacrolimus-treated kidney transplant recipients. Transplant Proc 2001;33(3):2148-50
  • Hodak SP, Moubarak JB, Rodriguez I, et al. QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. Transplantation 1998;66(4):535-7
  • duBell WH, Gaa ST, Lederer WJ, Rogers TB. Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricle. Am J Physiol 1998;275:H2041-52
  • Kong H, Jones PP, Koop A, et al. Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor. Biochem J 2008;414(3):441-52
  • Fu M, Li RX, Fan L, et al. Sarcoplasmic reticulum Ca2+ release channel ryanodine receptor (RyR2) plays a crucial role in aconitine-induced arrhythmias. Biochem Pharmacol 2008;75(11):2147-56
  • Fernandez-Velasco M, Gomez AM, Richard S. Unzipping RyR2 in adult cardiomyocytes: getting closer to mechanisms of inherited ventricular arrhythmias? Cardiovasc Res 2006;70(3):407-9
  • Venetucci LA, Trafford AW, Eisner DA. Increasing Ryanodine Receptor Open Probability Alone Does Not Produce Arrhythmogenic Calcium Waves. Threshold Sarcoplasmic Reticulum Calcium Content Is Required. Cir Res 2007;100:105-11
  • Bito V, Heinzel FR, Biesmans L, Antoons G. Sipido KRCrosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling. Cardiovasc Res 2008;77(2):315-24
  • Antoons G, Volders PG, Stankovicova T, et al. Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block. J Physiol 2007;579:147-60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.